Due to physical distancing, isolation and complications in accessing healthcare services worldwide, the current burden of COVID-19 exacerbates patients' ability to self-manage their preexisting conditions. Thanks to the digital health revolution, a new category of medicine known as digital therapeutics (DTx) can help those with chronic conditions navigate these new challenges.
We invite you to join Jessica Cooper, Regional VP of Business Development at Kaia Health, and Dr. Gary Smithson, Medical Director at Virgin Pulse, for a webinar replay to learn about the prevalence and cost of chronic conditions and how DTx can successfully be used to manage musculoskeletal (MSK) conditions.
A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended.
A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended. A simple bio or more information about the webinar speaker. No more than 5 sentences are recommended.